Cynthia Lynn Anderson - 21 Aug 2023 Form 4 Insider Report for Vistagen Therapeutics, Inc. (VTGN)

Role
CHIEF FINANCIAL OFFICER
Signature
/s/ Cynthia L. Anderson
Issuer symbol
VTGN
Transactions as of
21 Aug 2023
Net transactions value
$0
Form type
4
Filing time
23 Aug 2023, 13:09:47 UTC
Next filing
26 Jun 2024
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction VTGN Stock Option (right to buy) Award $0 +8,333 $0.000000 8,333 21 Aug 2023 Common Stock 8,333 $5.34 Direct F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 25% of the stock options vest on August 21, 2024 (the "Vesting Start Date") and 1/36th of the remaining number of shares vest monthly thereafter until all awarded shares are fully vested three (3) years after the Vesting Start Date.
F2 The stock options were granted in connection with the Reporting Person's appointment as Chief Financial Officer and pursuant to the Issuer's 2019 Omnibus Equity Incentive Plan.